Sign Up
OverviewAPI
The global market for preimplantation genetic testing is projected to reach a revenue of USD 6.72 billion by 2035, driven by the increasing occurrence of genetic diseases and advancements in technology. The U.S. market is estimated to garner the largest revenue, while Europe is expected to have the highest CAGR by 2035. The global home pregnancy tests market is projected to reach $2 billion by 2030, with the U.S. and China leading the growth.

Ask a question